Back to Search
FRANKIS ALMAGUEL, M.D, PH.D.
M.D, PH.D.
Specialist
NPI: 1427433762IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nuclear Imaging & Therapy Physician
Nuclear Medicine — Nuclear Imaging & Therapy
Code: 207UN0902X
ME159000(FL)A123708(CA)
SpecialistPrimary
Specialist
Code: 174400000X
A123708(CA)
CMS Specialties
PrimaryNUCLEAR MEDICINE
Education
LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE
Class of 2010
Research & Publications (6)
Activation and reversal of lipotoxicity in PC12 and rat cortical cells following exposure to palmitic acid.
PMID 18951473·J Neurosci Res·2009
7-preclinical
Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.
PMID 19293795·Br J Cancer·2009
8-other
Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids.
PMID 18513372·J Neurochem·2008
7-preclinical
Precursor IGF-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 And Bcl-X L expression through different signaling pathways in breast cancer cells.
PMID 18428028·Growth Factors·2008
8-other
Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.
PMID 18365867·Growth Factors·2007
8-other
Characterization of methyl-beta-cyclodextrin toxicity in NGF-differentiated PC12 cell death.
PMID 17292476·Neurotoxicology·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 175 N PLYMOUTH WAY
SAN BERNARDINO, CA 92408 - Phone
- (909) 648-2037
Quick Facts
- NPI
- 1427433762
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 16
- Publications
- 6
Are you this provider?
Claim Your Profile